What is Venus Concept Inc (VERO) stock price today?

Venus Concept Inc (VERO) currently trades at $0.31 per share. The stock has a market capitalization of $578190.00 and a P/E ratio of —x.

Is VERO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Venus Concept Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 5/9 and Altman Z-Score is -6.98.

What is Venus Concept Inc's revenue and earnings?

Venus Concept Inc has trailing twelve-month (TTM) revenue of $58.88M with profit margins of -92.80%. Earnings per share (EPS) is $-45.26.

Is Venus Concept Inc financially healthy?

Venus Concept Inc's Piotroski F-Score is 5/9 (moderate financial health). The Altman Z-Score of -6.98 places it in the distress.

VERO

Venus Concept Inc

NASDAQ: VERO · HEALTHCARE · MEDICAL DEVICES

$0.31

+0.00% today

Updated 2026-04-30

Market cap

$578190.00

P/E ratio

—

P/S ratio

0.01x

EPS (TTM)

$-45.26

Dividend yield

—

52W range

$0 – $8

Volume

0.0M

Market cap

$578190.00

P/E ratio

—

P/S ratio

0.01x

EPS (TTM)

$-45.26

Dividend yield

—

52W range

$0 – $8

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

3.0

Quality

2.0

Profitability

5.0

Valuation

C+

5/9

Piotroski F-Score

Moderate

-7.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$10.60

+3313.85%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Altman Z -6.98 — distress zone

- Thin margins at -92.80%

- Negative free cash flow $-4.91M

- Revenue declining -8.20% QoQ

- Debt/equity 12.22x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$105.62M	$99.50M	$76.35M	$64.83M	$58.88M
Net income	$-22.14M	$-43.70M	$-37.25M	$-47.00M	$-22.57M
EPS	—	—	—	—	$-45.26
Free cash flow	$-20.28M	$-27.32M	$-12.97M	$-11.19M	$-4.91M
Profit margin	-20.96%	-43.92%	-48.79%	-72.49%	-92.80%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VERO	$578190.00	31	2.7	2.0	5.0	3.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Venus Concept Inc trades at $0.31. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -6.98, it sits in the distress. TTM revenue stands at $58.88M. with profit margins at -92.80%.

Frequently asked questions

What is Venus Concept Inc's stock price?

Venus Concept Inc (VERO) trades at $0.31.

Is Venus Concept Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Venus Concept Inc (VERO)?

The analyst target price is $10.60, representing +3313.8% upside from the current price of $0.31.

What is Venus Concept Inc's revenue?

TTM revenue is $58.88M.

Piotroski F-Score?

5/9 — moderate financial health.

Altman Z-Score?

-6.98 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.venus.ai

Quick metrics

P/S ratio0.01x

ROE-795.00%

Beta-0.06

50D MA$0.59

200D MA$1.82

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VERO vs LLY →VERO vs JNJ →VERO vs ABBV →Stock screener →